Skip to content

Press releases

Press releases

Kither Biotech announces publication of new data in Science Translational Medicine

Turin, Italy, 31 March 2022 – Data support the use of Kither Biotech’s lead asset, KIT2014, in obstructive airway diseases…
Read More
Press releases

Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer

Turin, Italy, 16 March 2022 – Kither Biotech (“Kither” or “the Company”), a biopharmaceutical company developing novel therapies for rare respiratory diseases…
Read More
Press releases

Kither Biotech welcomes Dr. Vincent Metzler as new Member of the Board

Turin, Italy, 18 June 2020 – We are pleased to announce that Dr. Vincent Metzler has joined the Board of Directors of Kither Biotech…
Read More
Press releases

Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases

Turin, Italy, 5 July 2019 – Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases
Read More